Publisher
Springer Science and Business Media LLC
Subject
Health Policy,Health (social science)
Reference122 articles.
1. AdSAT Working Group (2002) Assessment of adenoviral vector safety and toxicity: Report of the national institutes of health Recombinant DNA Advisory Committee (NIH Report). Human Gene Therapy 13(1): 3–13.
2. Allan, D.S. and Dubé, I.D. (1996) Symposium highlights: Future prospects for gene therapy. Transfusion Science 17(1): 203–205.
3. Amati, M.P. et al (2003) EMEA and gene therapy medicinal products development in the European Union. Journal of Biomedicine and Biotechnology 2003(1): 3–8.
4. Anderson, W.F. and Fletcher, J.C. (1980) Gene therapy in human beings: When is it ethical to begin? New England Journal of Medicine 303(22): 1293–1297.
5. Anderson, W.F. (1982) Human Genetic Engineering: Hearings before the Subcommittee on Investigations and Oversight of the Committee on Science and Technology. (Testimonial) U.S. House of Representatives, 97th Congress, 2nd Session, no. 170, Washington DC.
Cited by
12 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献